EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Role and cost effectiveness of bariatric surgery in T2DM

Jon Pinkney

Future Prescriber · 2013

DOI: 10.1002/fps.105 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Interest in bariatric surgery has gathered pace with wider awareness of its benefits for weight loss and for important weightrelated diseases, especially type 2 diabetes mellitus (T2DM). BS enables many patients with T2DM to achieve normal blood glucose levels and discontinue medication. This has generated lively debate about the role and cost‐effectiveness of BS in treating T2DM and whether BS should be offered more widely. Paradoxically, however, these discussions seldom examine the health service perspective. This article summarises recent evidence and asks whether BS could replace conventional treatment for some people with T2DM. Copyright © 2013 John Wiley & Sons, Ltd.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →